MGH-HMS Center for Nervous System Repair, Harvard Medical School, 50 Blossom Street, Boston, MA 02114, USA.
Nat Rev Neurol. 2010 Jul;6(7):363-72. doi: 10.1038/nrneurol.2010.73. Epub 2010 Jun 15.
Stem cell therapy is a potential treatment for spinal cord injury (SCI), and a variety of different stem cell types have been evaluated in animal models and humans with SCI. No consensus exists regarding the type of stem cell, if any, that will prove to be effective therapeutically. Most data suggest that no single therapy will be sufficient to overcome all the biological complications caused by SCI. Rationales for therapeutic use of stem cells for SCI include replacement of damaged neurons and glial cells, secretion of trophic factors, regulation of gliosis and scar formation, prevention of cyst formation, and enhancement of axon elongation. Most therapeutic approaches that use stem cells involve implantation of these cells into the spinal cord. The attendant risks of stem cell therapy for SCI--including tumor formation, or abnormal circuit formation leading to dysfunction--must be weighed against the potential benefits of this approach. This Review will examine the biological effects of SCI, the opportunities for stem cell treatment, and the types of stem cells that might be used therapeutically. The limited information available on the possible benefits of stem cell therapy to humans will also be discussed.
干细胞治疗是脊髓损伤 (SCI) 的一种潜在治疗方法,各种不同类型的干细胞已在 SCI 的动物模型和人类中进行了评估。关于哪种(如果有的话)干细胞将被证明在治疗上有效,尚无共识。大多数数据表明,没有单一的治疗方法足以克服 SCI 引起的所有生物学并发症。将干细胞用于 SCI 的治疗的基本原理包括替代受损的神经元和神经胶质细胞、分泌神经营养因子、调节神经胶质增生和瘢痕形成、预防囊肿形成以及增强轴突伸长。大多数使用干细胞的治疗方法都涉及将这些细胞植入脊髓。必须权衡干细胞治疗 SCI 的风险——包括肿瘤形成或导致功能障碍的异常电路形成——与这种方法的潜在益处。这篇综述将探讨 SCI 的生物学影响、干细胞治疗的机会以及可能用于治疗的干细胞类型。还将讨论有关干细胞治疗对人类可能带来的益处的有限信息。